Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1954 1
1956 1
1957 1
1959 1
1962 1
1963 6
1964 2
1965 5
1966 11
1967 12
1968 8
1969 13
1970 7
1971 10
1972 16
1973 19
1974 20
1975 20
1976 22
1977 21
1978 23
1979 25
1980 19
1981 24
1982 28
1983 31
1984 36
1985 50
1986 60
1987 51
1988 49
1989 57
1990 55
1991 61
1992 64
1993 85
1994 120
1995 93
1996 103
1997 113
1998 99
1999 107
2000 112
2001 112
2002 99
2003 109
2004 127
2005 108
2006 128
2007 130
2008 150
2009 141
2010 152
2011 153
2012 162
2013 157
2014 148
2015 164
2016 163
2017 151
2018 143
2019 146
2020 158
2021 172
2022 140
2023 120
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

4,559 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: shimada k. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
Prediction of tissue-of-origin of early stage cancers using serum miRNomes.
Matsuzaki J, Kato K, Oono K, Tsuchiya N, Sudo K, Shimomura A, Tamura K, Shiino S, Kinoshita T, Daiko H, Wada T, Katai H, Ochiai H, Kanemitsu Y, Takamaru H, Abe S, Saito Y, Boku N, Kondo S, Ueno H, Okusaka T, Shimada K, Ohe Y, Asakura K, Yoshida Y, Watanabe SI, Asano N, Kawai A, Ohno M, Narita Y, Ishikawa M, Kato T, Fujimoto H, Niida S, Sakamoto H, Takizawa S, Akiba T, Okanohara D, Shiraishi K, Kohno T, Takeshita F, Nakagama H, Ota N, Ochiya T; Project Team for Development and Diagnostic Technology for Detection of miRNA in Body Fluids. Matsuzaki J, et al. Among authors: shimada k. JNCI Cancer Spectr. 2023 Jan 3;7(1):pkac080. doi: 10.1093/jncics/pkac080. JNCI Cancer Spectr. 2023. PMID: 36426871 Free PMC article.
Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition.
Nagino M, Hirano S, Yoshitomi H, Aoki T, Uesaka K, Unno M, Ebata T, Konishi M, Sano K, Shimada K, Shimizu H, Higuchi R, Wakai T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I. Nagino M, et al. Among authors: shimada k. J Hepatobiliary Pancreat Sci. 2021 Jan;28(1):26-54. doi: 10.1002/jhbp.870. Epub 2020 Dec 23. J Hepatobiliary Pancreat Sci. 2021. PMID: 33259690
STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases.
Pham PT, Fukuda D, Nishimoto S, Kim-Kaneyama JR, Lei XF, Takahashi Y, Sato T, Tanaka K, Suto K, Kawabata Y, Yamaguchi K, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Shimada K, Kanematsu Y, Takagi Y, Shimabukuro M, Setou M, Barber GN, Sata M. Pham PT, et al. Among authors: shimada k. Eur Heart J. 2021 Nov 7;42(42):4336-4348. doi: 10.1093/eurheartj/ehab249. Eur Heart J. 2021. PMID: 34226923
TRPV4 channels promote vascular permeability in retinal vascular disease.
Nishinaka A, Tanaka M, Ohara K, Sugaru E, Shishido Y, Sugiura A, Moriguchi Y, Toui A, Nakamura S, Shimada K, Watanabe S, Hara H, Shimazawa M. Nishinaka A, et al. Among authors: shimada k. Exp Eye Res. 2023 Mar;228:109405. doi: 10.1016/j.exer.2023.109405. Epub 2023 Feb 9. Exp Eye Res. 2023. PMID: 36773739
4,559 results